Accenture has made a minority investment in 1QBit, a quantum computing firm based in Vancouver, British Columbia.
The IT services company said the move will help Accenture expand its capabilities in quantum computing analytics.
Accenture will be 1QBit’s preferred systems integrator. Accenture has also been granted a license to use the 1QBit platform for demonstration, training, and the development and testing of Accenture tools and assets.
Accenture will leverage its alliance with 1QBit to develop a quantum-inspired analytics capability through Accenture Analytics and scale pilot opportunities identified through the Accenture Labs.
1QBit builds quantum and quantum-inspired software to help organizations solve their demanding computational challenges. Its interdisciplinary team comprises mathematicians, physicists, chemists, software developers and quantum computing experts who develop novel solutions to problems, from research through to commercial application development.
“Accenture has a significant opportunity to extend our first-mover advantage in applying quantum computing to create breakthrough innovations that help clients solve their most complex business challenges,” said Paul Daugherty, Accenture’s chief technology & innovation officer.
“Establishing a relationship with Accenture enables us to tap their vast capabilities, and bring 1QBit’s expertise in quantum computing to a much broader base of clients,” said Andrew Fursman, 1QBit’s CEO and co-founder.
Earlier this year, Accenture and 1QBit announced that they collaborated with Biogen to develop a quantum-enabled molecular-comparison application that could speed up drug discovery for complex neurological conditions such as multiple sclerosis, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease.